ATP13A2 variability in Taiwanese Parkinson's disease (Q39516168)

12 September 2017

ATP13A2 variability in Taiwanese Parkinson's disease (English)

1 reference

12 September 2017

1 reference

I-Cheng Chen

8

0 references

Hsueh-Fen Juan

object named as

Hsueh-Fen Juan

3

0 references

author name string

Chiung-Mei Chen

1

1 reference

12 September 2017

Chih-Hsin Lin

2

1 reference

12 September 2017

Fen-Ju Hu

4

1 reference

12 September 2017

Ya-Chin Hsiao

5

1 reference

12 September 2017

Hsin-Yi Chang

6

1 reference

12 September 2017

Chih-Ying Chao

7

1 reference

12 September 2017

Li-Ching Lee

9

1 reference

12 September 2017

Tsu-Wei Wang

10

1 reference

12 September 2017

Ya-Tang Chen

11

1 reference

12 September 2017

Yi-Tsun Chen

12

1 reference

12 September 2017

Guey-Jen Lee-Chen

13

1 reference

12 September 2017

Yih-Ru Wu

14

1 reference

12 September 2017

28 June 2011

1 reference

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

12 September 2017

1 reference

12 September 2017

156B

1 reference

12 September 2017

6

1 reference

12 September 2017

720-729

1 reference

Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.

12 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

ATP13A2 variants in early-onset Parkinson's disease patients and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

The biology and enzymology of protein N-myristoylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Lack of association between ATP13A2 Ala746Thr variant and Parkinson's disease in Han population of mainland China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Rapid screening of ATP13A2 variant with high-resolution melting analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Deciphering the role of heterozygous mutations in genes associated with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Biology, structure and mechanism of P-type ATPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Parkinson's disease: from monogenic forms to genetic susceptibility factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

ATP13A2 G2236A variant is rare in patients with early-onset Parkinson's disease and familial Parkinson's disease from Mainland China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Characterization of the P5 subfamily of P-type transport ATPases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

ATP13A2 variability in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

PARK9-LINKED PARKINSONISM IN EASTERN ASIA: MUTATION DETECTION IN ATP13A2 AND CLINICAL PHENOTYPE

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31214

21 January 2018

Identifiers

DOI

10.1002/AJMG.B.31214

1 reference

12 September 2017

1 reference